Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,200 | 205 | 95.6% |
| Education | $146.92 | 4 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,443 | 98 | $0 (2024) |
| PFIZER INC. | $315.43 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $194.90 | 7 | $0 (2024) |
| Allergan Inc. | $154.53 | 13 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $119.33 | 8 | $0 (2024) |
| Organon Llc | $105.50 | 5 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $93.17 | 5 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $92.77 | 7 | $0 (2019) |
| Celgene Corporation | $91.44 | 5 | $0 (2023) |
| Boston Scientific Corporation | $85.72 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $648.13 | 34 | ABBVIE INC. ($304.25) |
| 2023 | $706.27 | 40 | AbbVie Inc. ($285.89) |
| 2022 | $246.69 | 15 | ABBVIE INC. ($188.97) |
| 2020 | $118.03 | 7 | AbbVie Inc. ($49.88) |
| 2019 | $512.11 | 34 | AbbVie, Inc. ($248.50) |
| 2018 | $624.63 | 45 | Allergan Inc. ($143.25) |
| 2017 | $491.00 | 34 | AbbVie, Inc. ($246.61) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Immunology | ||||||
| 10/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: VIROLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: VIROLOGY | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/08/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/27/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/22/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 07/16/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: VIROLOGY | ||||||
| 07/09/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $14.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.02 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 558 | 617 | $450,123 | $56,338 |
| 2022 | 15 | 693 | 742 | $554,270 | $69,456 |
| 2021 | 17 | 746 | 833 | $518,331 | $75,036 |
| 2020 | 14 | 819 | 904 | $601,886 | $85,528 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 130 | $26,720 | $8,012 | 30.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 42 | 42 | $66,582 | $5,831 | 8.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 29 | 29 | $56,484 | $5,640 | 10.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $23,876 | $5,524 | 23.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 67 | 68 | $86,222 | $5,234 | 6.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 26 | 26 | $40,048 | $4,212 | 10.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $16,017 | $3,669 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 39 | $12,099 | $3,534 | 29.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 57 | $12,911 | $3,120 | 24.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $32,879 | $2,969 | 9.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $10,807 | $2,515 | 23.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 12 | 12 | $18,472 | $2,015 | 10.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 27 | 27 | $28,660 | $2,008 | 7.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 11 | 12 | $14,130 | $1,224 | 8.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 13 | $4,216 | $832.39 | 19.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 61 | 61 | $113,559 | $11,506 | 10.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 139 | 168 | $32,764 | $9,914 | 30.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 95 | 95 | $113,981 | $6,785 | 6.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 62 | 62 | $93,280 | $6,732 | 7.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 74 | $21,789 | $6,384 | 29.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $26,357 | $6,234 | 23.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 29 | 29 | $42,322 | $4,768 | 11.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 67 | 67 | $19,417 | $4,767 | 24.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 22 | 22 | $29,836 | $3,003 | 10.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $10,744 | $2,609 | 24.3% |
About Dr. Bennett Bruckner, M.D
Dr. Bennett Bruckner, M.D is a Gastroenterology healthcare provider based in Spartanburg, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639270622.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bennett Bruckner, M.D has received a total of $3,347 in payments from pharmaceutical and medical device companies, with $648.13 received in 2024. These payments were reported across 209 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,200).
As a Medicare-enrolled provider, Bruckner has provided services to 2,816 Medicare beneficiaries, totaling 3,096 services with total Medicare billing of $286,357. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Spartanburg, SC
- Active Since 09/25/2006
- Last Updated 12/08/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1639270622
Products in Payments
- XELJANZ (Drug) $315.43
- Mavyret (Drug) $253.65
- Humira (Biological) $244.55
- RINVOQ (Biological) $214.21
- CREON (Drug) $189.18
- LINZESS (Drug) $179.74
- STELARA (Biological) $160.90
- MAVYRET (Drug) $142.55
- Amitiza (Drug) $106.13
- HADLIMA (Drug) $105.50
- SKYRIZI (Biological) $101.32
- ZEPOSIA (Drug) $91.44
- XIFAXAN (Drug) $88.80
- APOLLO ESG System (Device) $85.72
- VIBERZI (Drug) $75.70
- Trulance (Drug) $73.23
- BOTOX - UROLOGY (Drug) $58.67
- ZEPATIER (Drug) $49.76
- IBSRELA (Drug) $46.49
- INJECTAFER (Drug) $45.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Spartanburg
Dr. Peter Kobes, Md, MD
Gastroenterology — Payments: $10,976
Dr. Haywood France, Md, MD
Gastroenterology — Payments: $7,117
Dr. Walter Douglass, Md, MD
Gastroenterology — Payments: $6,745
Dr. Albert Mossburg, Md, MD
Gastroenterology — Payments: $6,003
Dr. Thomas Montagne, Md, MD
Gastroenterology — Payments: $5,250
Albert Fedalei, Md, MD
Gastroenterology — Payments: $3,468